Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background The field of mechanical circulatory support has been impacted by the approval
of new continuous-flow left ventricular assist devices (LVADs) and changes to the United …

Aim The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left
ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

TaggedPIn 2013, the International Society for Heart and Lung Transplantation (ISHLT)
published the first official guidelines for implantable mechanical circulatory support (MCS) …

Infective endocarditis (IE), initially described more than 350 years ago, involves infection of
the endocardial surface of the heart. The clinical manifestations of IE can involve every …

Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage
heart failure patients with> 22 000 implantations to date. Though originally conceived for …

Over 25 years ago, it became clear that heart transplantation would become a treatment
option for only a limited group of carefully selected patients with advanced heart failure (HF) …